Methods for treatment and prevention of otitis media using chemical penetration enhancers to facilitate transmembrane drug delivery into the middle ear

Details for Australian Patent Application No. 2006295236 (hide)

Owner Piedmont Pharmaceuticals LLC

Inventors Johnson, Roland H.; Campbell, William R.; Paulsen, Neil E.

Agent Freehills

Pub. Number AU-A-2006295236

PCT Pub. Number WO2007/037874

Priority 60/720,535 26.09.05 US

Filing date 24 August 2006

Wipo publication date 5 April 2007

International Classifications

A61K 31/045 (2006.01) - Hydroxy compounds, e.g. alcohols

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/037874 Priority application(s): WO2007/037874

22 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006295245-Handheld communication tester and method for testing direct serial communication capability of an intelligent electronic device in a power system

2006295235-Method for making a scour medium and use of such medium in a method for producing rutile titanium dioxide